Abstract
Colon cancer is the second leading cause of cancer-related death in the Western world. Approximately 80-90% of colon cancers develop in adenomas after mutations. The risk of encountering malignancy increases with the size of the adenomatous polyp. It is approximately 1% in adenomas <1 cm, and increases to 10% for adenomas 1-2 cm, and 20-53% for adenomas >2 cm. CT colonography (CTC) is a new technique, which allows, after bowel preparation and distension of the cleansed colon, to generate a volumetric display of the colon. Multi-detector CTC has a sensitivity of 93-100% and 70-83% for detection of polyps sized >=10 mm and 6-9 mm, respectively. For detection of colorectal cancer, CTC has a sensitivity of 83-100%. CTC is especially of value in patients with incomplete colonoscopy due to stenosis or colon elongation. It reliably detects synchronous cancers proximal to occlusive colon cancers, when colonoscopy fails to evaluate the entire colon. First results of a colon cancer screening study have shown that CTC is equal or even slightly superior to conventional colonoscopy in detection of adenomatous polyps >=8 mm. Moreover, CTC detects clinically significant extracolonic abnormalities not shown by colonoscopy. To increase the patient acceptance for wide-spread application of CTC cancer screening the issue of patient discomfort by bowel preparation and radiation exposure needs to be addressed further.